Swiss pharmaceutical giant Novartis said Monday it had filed a lawsuit in the United States against Israeli generic drugmaker Teva, over patents for two medications to treat bone diseases.
The lawsuit, which was filed on Thursday, aims to prevent Teva -- the world's largest generic drug company -- from selling generic versions of the two drugs, Zometa and Reclast, until their patents expire in 2013, a Novartis spokesman said.
The details can be read here.
No comments:
Post a Comment